Filtros : "FO-ODE" "IME" "Financiado pelo MCTI" Limpar

Filtros



Refine with date range


  • Source: PLOS ONE. Unidades: IME, FO, IQ, FM

    Subjects: BIOINFORMÁTICA, NEOPLASIAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LOBBA, Aline Ramos Maia et al. High CD90 (THY-1) expression positively correlates with cell transformation and worse prognosis in basal-like breast cancer tumors. PLOS ONE, v. 13, n. 6, p. 1-21, 2018Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0199254. Acesso em: 10 nov. 2024.
    • APA

      Lobba, A. R. M., Carreira, A. C. O., Cerqueira, O. L. D., Fujita, A., DeOcesano-Pereira, C., Osorio, C. A. B., et al. (2018). High CD90 (THY-1) expression positively correlates with cell transformation and worse prognosis in basal-like breast cancer tumors. PLOS ONE, 13( 6), 1-21. doi:10.1371/journal.pone.0199254
    • NLM

      Lobba ARM, Carreira ACO, Cerqueira OLD, Fujita A, DeOcesano-Pereira C, Osorio CAB, Soares FA, Rameshwar P, Sogayar MC. High CD90 (THY-1) expression positively correlates with cell transformation and worse prognosis in basal-like breast cancer tumors [Internet]. PLOS ONE. 2018 ; 13( 6): 1-21.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1371/journal.pone.0199254
    • Vancouver

      Lobba ARM, Carreira ACO, Cerqueira OLD, Fujita A, DeOcesano-Pereira C, Osorio CAB, Soares FA, Rameshwar P, Sogayar MC. High CD90 (THY-1) expression positively correlates with cell transformation and worse prognosis in basal-like breast cancer tumors [Internet]. PLOS ONE. 2018 ; 13( 6): 1-21.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1371/journal.pone.0199254
  • Source: BMC Cancer. Unidades: IME, FO, IQ

    Subjects: IMUNOHISTOQUÍMICA, NEOPLASIAS MAMÁRIAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GOMES, Luciana Rodrigues et al. RECK is not an independent prognostic marker for breast cancer. BMC Cancer, v. 15, p. 1-11 art. 660, 2015Tradução . . Disponível em: https://doi.org/10.1186/s12885-015-1666-2. Acesso em: 10 nov. 2024.
    • APA

      Gomes, L. R., Fujita, A., Mott, J. D., Soares, F. A., Labriola, L., & Sogayar, M. C. (2015). RECK is not an independent prognostic marker for breast cancer. BMC Cancer, 15, 1-11 art. 660. doi:10.1186/s12885-015-1666-2
    • NLM

      Gomes LR, Fujita A, Mott JD, Soares FA, Labriola L, Sogayar MC. RECK is not an independent prognostic marker for breast cancer [Internet]. BMC Cancer. 2015 ; 15 1-11 art. 660.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1186/s12885-015-1666-2
    • Vancouver

      Gomes LR, Fujita A, Mott JD, Soares FA, Labriola L, Sogayar MC. RECK is not an independent prognostic marker for breast cancer [Internet]. BMC Cancer. 2015 ; 15 1-11 art. 660.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1186/s12885-015-1666-2

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024